Close Menu

NEW YORK – Exact Sciences and the Mayo Clinic announced today that they have initiated a study to analyze the real-world impact of the company's Cologuard colorectal cancer diagnostic test on colorectal cancer screening, incidence, and mortality rates.

The Voyage study is a prospective, observational study designed to enroll more than 150,000 people with a valid Cologuard order. The researchers will follow participants for at least seven years to evaluate clinical outcomes, Exact said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The University of California, Berkeley's Jennifer Doudna reflects at Science on the anniversary of the announcement of the birth of twin girls who underwent genome editing.

By studying its enamel proteome, researchers have found the ancient ape Gigantopithecus blacki belongs to a sister clade to that of orangutans.

Bloomberg Businessweek discusses genomics with BGI's Wang Jian.

In Science this week: researchers find transplanting the gut microbiome in mice affects physiology, and more.